Reduced skin homing by functional Treg in vitiligo

Pigment Cell and Melanoma Research

Volumn 23, Issue 2, 2010, Pages 276-286

  Klarquist, Jared ^a   Denman, Cecele J ^a   Hernandez, Claudia ^b   Wainwright, Derek J ^a   Strickland, Faith M ^c   Overbeck, Andreas ^d   Mehrotra, Shikar ^e   Nishimura, Michael I ^e   Le Poole, I Caroline ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d Lumiderm   (Spain)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Autoimmune; Depigmentation; T cells; Tolerance

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5 ANTAGONIST; CHEMOKINE RECEPTOR CCR8; CUTANEOUS LYMPHOCYTE ASSOCIATED ANTIGEN; INSULIN; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; MACROPHAGE DERIVED CHEMOKINE; NAFTIFINE; TACROLIMUS; TAMOXIFEN; TRANSCRIPTION FACTOR FOXP3;

ADOLESCENT; ADULT; ARTICLE; CELL ACTIVITY; CELL FUNCTION; CELL HOMING; CELL INFILTRATION; CELL MIGRATION; CELL SELECTION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LASER; LYMPHOCYTE; MALE; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SKIN; SKIN BLOOD FLOW; SKIN CELL; SKIN DEFECT; VITILIGO;

ADOLESCENT; ADULT; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; FEMALE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; RECEPTORS, CCR4; RECEPTORS, CCR5; RECEPTORS, CCR8; SKIN; T-LYMPHOCYTES, REGULATORY; VITILIGO; YOUNG ADULT;

EID: 77949409205     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2010.00688.x     Document Type: Article

References (41)

1. Al-Mutairi, N., and Al-Doukhi, A. (2009). Familial coexisting and colocalized psoriasis and vitiligo responding to alefacept. J. Cutan. Med. Surg. 13, 172-175.
2. Baecher-Allen, C., and Hafler, D.A. (2006). Human regulatory T cells and their role on autoimmune disease. Immunol. Rev. 212, 203-216.
3. Bala, K.K., and Moudgil, K.D. (2006). Induction and maintenance of self tolerance: the role of CD4+CD25+ regulatory T cells. Arch. Immunol. Ther. Exp. (Warsz) 54, 307-321.
4. Chakraborty, N.G., Chattopadhyay, S., Mehrotra, S., Chhabra, A., and Mukherji, B. (2004). Regulatory T-cell reponse and tumor vaccine-induced cytotoxic T lymphocytes in human melanoma. Hum. Immunol. 65, 794-802.
5. Colantonio, L., Iellem, A., Sinigaglia, F., and D'Ambrosio, D. (2002). Skin-homing CLA+ T cells and regulatory CD25+ T cells represent major subsets of human peripheral blood memory T cells migrating in response to CCL1 ? I-309. Eur. J. Immunol. 32, 3506-3514.
6. Danese, S., and Rutella, S. (2007). The Janus face of CD4+CD25+ regulatory T cells in cancer and autoimmunity. Curr. Med. Chem. 14, 649-666.
7. Dannull, J., Su, Z., Rizzieri, D. et al. (2005). Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells. J. Clin. Invest. 115, 3622-3633.
8. Das, P.K., van den Wijngaard, R.M.J.G.J., Wankowicz-Kalinska, A., and Le Poole, I.C. (2001). A symbiotic concept of autoimmunity and tumour immunity: lessons from vitiligo. Trends Immunol. 22, 130-136.
9. De Boer, O.J., van der Loos, C.M., Teeling, P., van der Wal, A.C., and Teunissen, M.B. (2007). Immunohistochemical analysis of regulatory T cell markers FOXP3 and GITR on CD4+CD25+ T cells in normal skin and inflammatory dermatoses. J. Histochem. Cytochem. 55, 891-898.
10. Denman, C.J., McCracken, J., Hariharan, V., Klarquist, J., Oyarbide-Valencia, K., Guevara-Patiño, J.A., and Le Poole, I.C. (2008). HSP70i accelerates depigmentation in a mouse model of autoimmune vitiligo. J Invest Dermatol. 128, 2041-2048.
11. Goodman, W.A., Levine, A.D., Massari, J.V., McCormick, T.S., and Cooper, K.D. (2009). IL-6 signalling in psoriasis prevents immune suppression by regulatory T cells. J. Immunol. 183, 3170-3176.
12. Hernandez, C., Reddy, S.G., Barfuss, A., and Le Poole, I.C. (2008). Contact leucoderma after application of a compounded phenol cream and narrowband-UVB. Eur. J. Dermatol. 18, 593-595.
13. Hirahara, K., Liu, L., Clark, R.A., Yamanaka, Y., Fuhlbrigge, R.C., and Kupper, T.S. (2006). The majority of human peripheral blood CD4+CD25+highFoxp3+ regulatory T cells bear functional skinhoming receptors. J. Immunol. 177, 4488-4494.
14. Iellem, A., Colantonio, L., and D'Ambrosio, D. (2003). Skin-versus gut-skewed homing receptor expression and intrinsic CCR4 expression on human peripheral blood CD4+CD25+ suppressor T cells. Eur. J. Immunol. 33, 1488-1496.
15. Jacob, J.B., Kong, Y.C., Nalbantoglu, I., Snower, D.P., and Wei, W.Z. (2009). Tumor regression follwong DNA vaccination and regulatory T cell depletion in neu transgenic mice leads to an increased risk for autoimmunity. J. Immunol. 182, 5873-5878.
16. Joetham, A., Takeda, K., Taube, C., Miyahara, N., Matsubara, S., Koya, T., Rha, Y.N., Dakhama, A., and Gelfand, E.W. (2007). Naturally occurring lung CD4(+)CD25(+) T cell regulation of airway allergic responses depends on IL-10 induction of TGF-β. J. Immunol. 178, 1433-1442.
17. Kakourou, T., Kanaka-Gantenbein, C., Papadopoulou, A., Kaloumenou, E., and Chrousos, G.P. (2005). Increased prevalence of chronic autoimmune (Hashimoto's) thyroiditis in children and adolescents with vitiligo. J. Am. Acad. Dermatol. 53, 220-223.
18. Klarquist, J., McKee, M., Mehrotra, S., and Le Poole, I.C. (2009). Markedly enhanced expression of homing receptors by cicultating Treg in melanoma. Pigment Cell Melanoma Res. 22, 498 (abstract).
19. Lahl, K., Loddenkemper, C., Drouin, C., Freyer, J., Arnason, J., Eberl, G., Hamann, A., Wagner, H., Huehn, J., and Sparwasser, T. (2007). Selective depletion of Foxp3 regulatory T cells induces a scurfy-like disease. J. Exp. Med. 204, 57-63.
20. Le Poole, I.C., van den Wijngaard, R.M.J.G.J., Westerhof, W., Dutrieux, R.P., and Das, P.K. (1993). Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation. J. Invest. Dermatol. 100, 816-822.
21. Le Poole, I.C., Riker, A.I., Quevedo, M.E., Stennett, L.S., Wang, E., Marincola, F.M., Kast, W.M., Robinson, J.K., and Nickoloff, B.J. (2002). Interferon-γ reduces melanosomal antigen expression and recognition of melanoma cells by cytotoxic T cells. Am. J. Pathol. 160, 521-528.
22. Le Poole, I.C., Denman, C.J., and Arbiser, J.L. (2008). Immunosuppression may be present within condylomata acuminata. J. Am. Acad. Dermatol. 59, 967-974.
23. Lee, H.Y., Hong, Y.K., Yun, H.J., Kim, Y.M., Kim, J.R., and Yoo, W.H. (2008). Altered frequency and migration capacity of CD4+CD25+ regulatory T cells in systemic lupus erythematosus. Rheumotology 47, 789-794.
24. Loddenkemper, C., Hoffmann, C., Stanke, J. et al. (2009). Regulatory (FOXP3+) T cells as target for immune therapy of cervical intraepithelial neoplasia and cervical cancer. Cancer Sci. 100, 1112-1117.
25. Mahnke, K., Schönfeld, K., Fondel, S. et al. (2007). Depletion of CD4(+)CD25(+) human regulatory T cells in vivo Kinetics of Treg depletion and alterations in immune functions in vivo and in vitro. Int. J. Cancer 120, 2723-2733.
26. McFadden, C., Morgan, R., Rahangdale, S., Green, D., Yamasaki, H., Center, D., and Cruikshank, W. (2007). Preferential migration of T regulatory cells induced by IL-16. J. Immunol. 179, 6439-6445.
27. Nair, S., Boczkowski, D., Fasnacht, M., Pisetsky, D., and Gilboa, E. (2007). Vaccination against the forkhead family transcription factor Foxp3 enhances tumor immunity. Cancer Res. 67, 371-380.
28. Ogg, G.S., Rod Dunbar, P., Romero, P., Chen, J.L., and Cerundolo, V. (1998). High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo. J. Exp. Med. 188, 1203-1208.
29. Oyarbide-Valencia, K., van den Boorn, J.G., Denman, C.J., Carlson, J.M., Hernandez, C., Nishimura, M.I., Das, P.K., Luiten, R.M., and Le Poole, I.C. (2006). Therapeutic implications of autoimmune vitiligo T cells. Autoimmun. Rev. 5, 486-492.
30. Pan, J., Zhang, M., Wang, J., Wang, Q., Xia, D., Sun, W., Zhang, L., Yu, H., Liu, Y., and Cao, X. (2004). Interferon-gamma is an autocrine mediator for dendritic cell maturation. Immunol. Lett. 94, 141-151.
31. Siewert, C., Menning, A., Dudda, J., Siegmund, K., Lauer, U., Floess, S., Campbell, D.J., Hamann, A., and Huehn, J. (2007). Induction of organ-selective CD4+ regulatory T cell homing. Eur. J. Immunol. 37, 978-989.
32. Smyk-Pearson, S., Golden-Mason, L., Klarquist, J., Burton, J.R., Tester, I.A., Wang, C.C., Culbertson, N., Vandenbark, A.A., and Rosen, H.R. (2008). Functional suppression by FoxP3+CD4+ CD25(high) regulatory T cells during acute hepatitis C virus infection. J. Infect. Dis. 197, 46-57.
33. Sugiyama, H., Gyulai, R., Toichi, E., Garaczi, E., Shimada, S., Stevens, S.R., McCormick, T.S., and Cooper, K.D. (2005). Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J. Immunol. 174, 164-173.
34. Sutmuller, R.P., van Duivenvoorde, L.M., van Elsas, A., Schumacher, T.N., Wildenberg, M.E., Allison, J.P., Toes, P.E., Offringa, R., and Melief, C.J. (2001). Synergism of cytotoxic T lymphocyteassociated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive T lymphocyte responses. J. Exp. Med. 194, 823-832.
35. Taieb, A., Picardo, M., and VETF Members (2007). The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res. 20, 27-35.
36. Van den Boorn, J.G., Le Poole, I.C., and Luiten, R.M. (2006). T cell avidity and tuning: the flexible connection between tolerance and autoimmunity. Int. Rev. Immunol. 25, 235-258.
37. Van den Wijngaard, R., Wankowicz-Kalinska, A., Le Poole, I.C., Tigges, B., Westerhof, W., and Das, P.K. (2000). Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site. Lab. Invest. 80, 1299-1309.
38. Visseren, M.J., van Elsas, A., van der Voort, E.I., Ressing, M.E., Kast, W.M., Schrier, P.I., and Melief, C.J. (1995). CTL specific for the tyrosinase autoantigen can be induced from healthy donor blood can lyse melanoma cells. J. Immunol. 154, 3991-3998.
39. Wankowicz-Kalinska, A., van den Wijngaard, R.M.J.G.J., Tigges, B.J., Westerhof, W., Ogg, G.S., Cerundolo, V., Storkus, W.J., and Das, P.K. (2003). Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo. Lab. Invest. 83, 683-695.
40. Zheng, Y., and Rudensky, A.Y. (2007). FoxP3 in control of the regulatory T cell lineage. Nat. Immunol. 8, 457-462.
41. Zhu, J., and Paul, W.W. (2008). CD4 T cells: fates, functions, and faults. Blood 112, 1557-1569.